Supplementary Table S1-S10 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer

Jingyu Zang,Akezhouli Shahatiaili,Mei-Chun Cai,Di Jin,Peiye Shen,Lei Qian,Lu Zhang,Tianxiang Zhang,Yuchen Wu,Fan Yang,Zheng Wu,Yanli Hou,Yongrui Bai,Jun Xia,Liang Cheng,Ruiyun Zhang,Guanglei Zhuang,Haige Chen

DOI: https://doi.org/10.1158/1078-0432.27434422

2024-01-01

Abstract:Table S1. Quality control of sequencing data. Table S2. Representativeness of study participants. Table S3. Clinicopathological characteristics of 35 patients diagnosed with NEBC. Table S4. Summary of clinicopathological characteristics for the NEBC cohort. Table S5. Comparing clinical characteristics of patients in the NEBC and UBC cohort before and after PSM. Table S6. Whole genome sequencing statistics of 19 patients in NEBC cohort. Table S7. Density of immune cells in CT and IM region and immunotypes of patients in NEBC cohort. Table S8. Cell density and Ki-67 expresion in NEBC region and UBC region of patients diagnosed with mixed-UBC. Table S9. Clinical characteristics of metastatic NEBC patients receiving systemic treatment. Table S10. Clinical characteristics and density of immune cells of patients receiving neoadjuvant treatment.